Sorry, you need to enable JavaScript to visit this website.

Competitive Grants Program

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Optimizing Antimicrobial Stewardship (AMS) Interventions and Outcomes in Clinical Outcomes, Optimal Use and Resource Utilizatio
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology China
    Optimizing Disease Management to Improve Alopecia Areata Quality of Care
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Inflammation & Immunology China
    Research on Exploring Disease Assessment and Prioritizing Systematic Treatment for Vitiligo
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology China
    Quality Improvement in Molecular Testing Pathways for Metastatic Colorectal Cancer (mCRC)
    Release Date:
    Partner: American Society for Clinical Pathology (ASCP)
    Review Process: Expert Review Panel
    Quality Improvement Oncology USA
    Personalized monitoring&treatment for HR+, HER2- mBC patients treated w CDK4/6i: incorporating Patient complexity risk factors
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement, Research Oncology Italy
    Providing Appropriate Medical Care for IBD Patients
    Release Date:
    Partner: Japanese Society for Inflammatory Bowel Disease (JSIBD)
    Review Process: Expert Review Panel
    Translation: Japanese (link)
    Quality Improvement Inflammation & Immunology Japan
    Administration of brentuximab vedotin alone or in combination with other approved agents in pre and/or peri CAR-T
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology USA
    Fostering Educational Initiatives for ALK+ Metastatic Non-Small Cell Lung Cancer(mNSCLC) Tyrosine Kinase Inhibitors(TKI) Therapy
    Release Date:
    Review Process: Pfizer Internal
    Translation: French (link)
    Education Oncology Canada
    2026 Inflammatory Bowel Disease (IBD) Fellowship- United States
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Inflammation & Immunology USA
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Optimizing maternal immunization practice in Saudi Arabia
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Vaccines Saudi Arabia
    Role of Maintenance Therapy in HER2+ Metastatic Breast Cancer (MBC)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Projects of Equalization of Cancer Information
    Release Date:
    Partner: Japanese Society of Clinical Oncology
    Review Process: Expert Review Panel
    Translation: Japanese (link)
    Quality Improvement Oncology Japan
    Initiatives for Healthcare Professionals to Promote Intramuscular Vaccination Methods for Children
    Release Date:
    Review Process: Expert Review Panel
    Translation: Japanese (link)
    Quality Improvement Vaccines Japan
    Efforts to Improve Quality of Migraine Medical Care
    Release Date:
    Partner: The Japanese Headache Society
    Review Process: Expert Review Panel
    Translation: Japanese (link)
    Quality Improvement Internal Medicine Japan
    Novel Therapies for Relapsed/Refractory Large B-Cell Lymphoma in Community Oncology Practice
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Improving the Care of Patients with Metastatic Breast Cancer (mBC) Through Innovative Strategies
    Release Date:
    Partner: The National Comprehensive Cancer Network® (NCCN)
    Review Process: Expert Review Panel
    Quality Improvement Oncology USA
    Improving Vaccination Systems and Environments to Promote prevention of Respiratory Infections in Older Adults
    Release Date:
    Review Process: Expert Review Panel
    Translation: Japanese (link)
    Quality Improvement Vaccines Japan
    Clinical Research Capability Development in China
    Release Date:
    Review Process: Pfizer Internal
    Education Support for the Professions China
    Developing Educational Initiatives for Implementation and Therapy Management of BCMA BsAbs in RRMM
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Optimizing the Experience of Patients with Bladder Cancer Through Multi-Disciplinary Care
    Release Date:
    Partner: Conquer Cancer, the ASCO Foundation
    Review Process: Expert Review Panel
    Quality Improvement Oncology USA
    The Enhancement of Management of breast cancer in French speaking Sub-Saharan African Countries
    Release Date:
    Partner: AMFROM
    Review Process: Expert Review Panel
    Translation: French (link)
    Quality Improvement Oncology Benin, Congo, The Democratic Republic, Mali, Senegal, Togo